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ABSTRACT
Intracranial Atherosclerotic Stenosis (ICAS) is associated with 8 to 10% of all
strokes in the U.S. Although there is some evidence that in the Asian population
inflammation plays a role in asymptomatic ICAS, it has not been shown in the U.S.
population. Prior studies have shown associations between diet and regulation of
inflammation. Mediterranean dietary pattern has been associated with lower levels of
inflammation and cardiovascular disease (CVD). In light of the important role of
inflammation in intermediate stroke risk factors including atherosclerotic disease, and
potential role of diet in modulating inflammation, understanding individuals’ diets
according to their inflammatory properties could yield important information about the
links between diet, inflammation, and ischemic stroke. Our objectives for this study were
two-fold. First, we assessed if high sensitivity C-reactive protein (hs-CRP), a marker of
inflammation is associated with asymptomatic ICAS. Second, we assessed if
Mediterranean dietary adherence is associated with ICAS, and if this association is
modified with individual’s inflammatory state.
Data came from the Atherosclerosis Risk in Communities Cohort, a communitybased, prospective cohort total of 15,792 participants, aged 45 to 64 years recruited
in1987 to 1989. We included 1,445 participants from this cohort who attended Visit 5
(2011-2013) and underwent high resolution MR angiography (MRA). MRA images were
analyzed in a centralized lab to assess ICAS (outcome) and ICAS was graded as: no
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stenosis, <50% stenosis, ≥50% stenosis/complete occlusion. Change in hs-CRP exposure)
was categorized as sustained low/moderate (<3 mg/L at visits 2 and 4); decreased (≥3
mg/L at visit 2 and <3 mg/L at visit 4); increased (<3 mg/L at visit 2 and ≥3 mg/L at visit
4); and sustained elevated (≥3 mg/L at both visits). Multinomial logistic regression
models were used to assess the association of 6-year change in hs-CRP with ICAS at visit
5. We also tested for the association between hs-CRP levels at each visit (categorized as
<1, 1-3 and >3 mg/l) and ICAS. Further to assess Mediterranean dietary adherence we
constructed an adapted Mediterranean Dietary Score (aMDS), that included the following
11 food components: non-refined cereals (whole grains), fruits, vegetables (excluding
potatoes), nuts, legumes, fish, monounsaturated-to-saturated fat ratio (as an alternative for
olive oil), red and processed meats, dairy products, poultry and alcohol. The aMDS
ranged from 0 to 55, with higher values indicating greater adherence to the Mediterranean
diet. Multinomial logistic regression models were used to assess the association between
the Tertiles of the aMDS and ICAS.
Our findings strongly suggest participants with elevated hs-CRP over a period of
6 years had a strong association with both moderate and severe ICAS. Participants with
increased hs-CRP over this 6 years period had increased odds for severe ICAS, however
those with deceased hs-CRP did not. Further, when assessing association between
Mediterranean diet and ICAS our results were somewhat suggestive of decreased burden
of ICAS with Mediterranean diet adherence however, these findings were not statistically
significant. Our findings also suggest inflammation (as measured by hs-CRP) may be an
effect modifier for the association between Mediterranean diet and ICAS, with those with
higher hs-CRP may benefit from Mediterranean diet adherence.
vi

Elevated hs-CRP was positively associated and asymptomatic ICAS after
controlling for potential confounders in a US population-based community study.
Inflammation may be a risk factor for ICAS in this group, and in those with chronic
inflammatory state adherence to Mediterranean diet can be beneficial.
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CHAPTER 1
INTRODUCTION
1.1 Statement of the problem
Stroke is the third leading cause of death in the United States. More than 140,000
people die each year from stroke in the United States (CDC). Recent data from the
American Heart Association indicate that strokes account for about one of every 18
deaths in the United States, whereas on average someone has a stroke every 40 seconds.
Despite recent advances in acute stroke treatment, effective primary stroke prevention, by
means of improved control of vascular risk factors, has the greatest potential to reduce its
burden (1).
Carotid stenosis and intracranial atherosclerotic disease (ICAD) are wellestablished vascular risk factors for ischemic stroke. Previous epidemiological studies
have shown inflammation is closely linked with atherogenesis. High sensitivity Creactive protein (hs-CRP), an indicator of inflammation, has been shown to be closely
related to vascular disease burden, including carotid stenosis, and more recently with
ICAD (2). A large prospective community-based study conducted in China, showed hsCRP is an independent predictor of intracranial atherosclerotic burden (2). In this study,
after adjusting for possible risk factors, high level of hs-CRP (≥ 3 mg/l) remained
significantly associated with asymptomatic ICAD (Adjusted Odds Ratio: 1.28, 95% CI:
1.02–1.61).
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A mounting body of evidence from observational studies has shown associations
between diet and regulation of inflammation (hs-CRP and other pro-inflammatory
cytokines) (5-9). The western diet, rich in red meat, processed and
artificially sweetened food products, refined grains, high fat-dairy products, and sugarsweetened beverages has been linked with increased levels of inflammatory biomarkers
and increased risk for CVD (10). On the contrary, a Mediterranean dietary pattern, rich in
nuts, olive oil, legumes and fish, fruits and vegetables, moderate intake of wine, has been
associated with lower levels of inflammation and a reduced risk of CVD (11-14).
In light of the important role of inflammation in intermediate stroke risk factors
including atherosclerotic disease, and potential mediation of inflammation by diet,
classifying individuals’ diets according to their inflammatory properties could yield
important information about the links between diet, inflammation, and ischemic stroke.
Given the anti-inflammatory properties of Mediterranean diet, at least in part the
association between a Mediterranean diet and risk of stroke may be mediated by
intracranial atherosclerotic disease (ICAD). However, to our knowledge the direct
relationship between Mediterranean diet and ICAD has not been studied before.
1.2 Clinical significance
The relationship between diet and cardiovascular disease is well recognized,
however relationship between dietary modulation of inflammation and its association
with CVD is an emerging concept and has not been extensively studied, and not too much
emphasis is given in clinical practice. More specifically, dietary modulation of
inflammation, and its association with ICAD, an intermediate stroke risk factor, to our
knowledge has never been previously studied. Classifying individuals’ diets according to
their inflammatory properties could yield important information about the links between
2

diet, inflammation, and cardiovascular disease burden. This knowledge can be useful in
planning preventive strategies, by modulating and targeting dietary lifestyle changes, to
reduce cardiovascular risk factors.
1.3 Study objective, specific aims, and hypothesis
Our objectives for this study were two-fold. First, we assessed if high sensitivity
C-reactive protein, a marker of inflammation is associated with asymptomatic ICAS.
Here, we analyzed if change in hs-CRP (exposure) over a period of 6 years was
associated with ICAS. Second, we assessed if Mediterranean dietary adherence is
associated with ICAS, and if this association is modified with individual’s inflammatory
state. We developed an adapted Mediterranean dietary score, to reflect an individual’s
adherence to Mediterranean dietary patter diet and developed adjusted regression model
to assess its association with ICAS.
Our specific study aims for this project were:
Aim 1: To assess if hs-CRP, a marker for inflammation, is associated with latelife ICAD in a representative US population. Hypothesis: Inflammation is known to
increase risk for atherosclerotic disease. We hypothesized inflammation would be
associated with increased risk for intracranial atherosclerotic disease.
ii) Aim 2: Validation of modified Mediterranean Score in American Diet.
Hypothesis: Modified Med Score would have robust positive and inverse associations
with known dietary biomarkers validated in previous literature.
iii) Aim 3: To study the association between Mediterranean diet adherence and
intracranial atherosclerotic stenosis and assess if this association modified by
inflammation in a representative US population. Hypothesis: Mediterranean diet
adherence is known to be associated with reduced inflammation, reduced oxidative stress,
3

improved lipid profile, improved blood pressure, and weight reduction. All these markers
are associated with atherosclerotic disease. We hypothesized adherence to Mediterranean
diet would be associated with a lower burden of ICAS, and individuals with higher
inflammatory markers may be benefit more from Mediterranean diet adherence.
1.4 Study Outline
Chapter 2 of this dissertation provides details for our study design and analyses
dedicated towards our first study Aim. Here we assessed our hypotheses that high
sensitivity C-reactive protein is associated with asymptomatic ICAS in the U.S.
population. Chapter 3 narrates our construction of an alternative Mediterranean dietary
pattern score and its validation with known biomarkers. This would serve as an
intermediate step for our next aim. Chapter 4 will be the manuscript for Aim 3 “study the
association between Mediterranean diet adherence and intracranial atherosclerotic
stenosis and assess if this association modified by inflammation in a representative US
population.” Chapter 5 includes a summary of each of the findings and an overall
synthesis of the results, suggestions for future research, and conclusions.
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CHAPTER 2
ASSOCIATION OF SUSTAINED INCREASED HIGH SENSITIVITY CREACTIVE PROTEIN WITH INTRACRANIAL ATHEROSCLEROTIC
STENOSIS IN THE US POPULATION
2.1 Abstract
Introduction and Hypothesis: Intracranial Atherosclerotic Stenosis (ICAS) is
associated with 8 to 10% of all strokes in the U.S. Although there is evidence that in the
Asian population inflammation plays a role in asymptomatic ICAS, it has not been shown
in the U.S. population. We assessed the hypotheses that high sensitivity C-reactive
protein (hs-CRP), a marker of inflammation is associated with asymptomatic ICAS.
Methods: The Atherosclerosis Risk in Communities Cohort is a communitybased, prospective cohort total of 15,792 participants, aged 45 to 64 years recruited
in1987 to 1989. We included 1,445 ARIC participants attended Visit 5 (2011-2013) and
underwent high resolution MR angiography (MRA), and also had data for hs-CRP
measured at visits 2 (1990-92) and 4 (1996-98). MRA images were analyzed in a
centralized lab to assess ICAS (outcome) and ICAS was graded as: no stenosis, <50%
stenosis, ≥50% stenosis/complete occlusion. Change in hs-CRP (exposure) was
categorized as sustained low/moderate (<3 mg/L at visits 2 and 4); decreased (≥3 mg/L at
visit 2 and <3 mg/L at visit 4); increased (<3 mg/L at visit 2 and ≥3 mg/L at visit 4); and
sustained elevated (≥3 mg/L at both visits). Multinomial logistic regression models were
5

used to assess the association of 6-year change in hs-CRP with ICAS at visit 5. We also
tested for the association between hs-CRP levels at each visit (categorized as <3 and ≥3
mg/l) and ICAS.
Results: Mean age of study participants (at visit 4) was 63±6, 42% were male,
81% were Caucasian and 19% were African-American. Compared to the participants
with sustained low/moderate hs-CRP over the 6 years period, those with sustained
elevated hs-CRP were more likely to have both moderate and severe ICAS (ORs [95%
CIs]: 1.57 [1.10, 2.27] and 1.66 [1.03, 2.84], respectively). Persons with increased hsCRP (<3 to ≥3 mg/L) had increased odds for severe ICAS (but not moderate ICAS),
however those with decreased hs-CRP did not. Associations for elevated hs-CRP level
(>3 mg/l at any visit) and ICAS were greater for those with increased hs-CRP at Visit 4,
but not at Visit 2.
Conclusions: Elevated hs-CRP was positively associated and asymptomatic
ICAS after controlling for potential confounders in a US population-based community
study. Inflammation may be a risk factor for ICAS in this group.
2.2 Introduction
Intracranial Atherosclerotic Stenosis (ICAS) is associated with 8 to 10% of all
strokes in the United States (U.S.) (15,16) and 30%-50% of strokes in Asian population
(17), making it one of the most common risk factors for stroke worldwide (18). Among
patients with severe ICAS, the annual risk of recurrent stroke is ~14% despite targeted
medical management (19).
Several epidemiological studies have shown geographic and ethnic differences in
the prevalence of ICAS. ICAS is more frequently encountered in Asians, whereas
extracranial carotid artery disease is more common in Western populations (20,21). Data
6

from epidemiological studies from the U.S. suggest ICAS preferentially affects Hispanics
and Blacks as compared to Whites (15,16). Etiology of such ethnic differences is not
clear, however environmental, and genetic factors have been implicated.
Inflammation, as measured by proinflammatory biomarkers like high sensitivity
C-reactive protein (hs-CRP), has been shown to be closely related to cardiovascular
events such as acute coronary syndrome, coronary artery disease, peripheral vascular
disease, metabolic syndrome and stroke (21-26). Data for the role of inflammation as a
risk factor for the development and progression for ICAS is limited, especially in the
Western

population. More recently, a community-based study conducted with an Asian

population, showed hs-CRP is an independent predictor of asymptomatic ICAS (27).
Although there is evidence in the Asian population inflammation plays a role in
asymptomatic ICAS, to our knowledge this has not been studied in the U.S. population.
Considering possible role of the environmental and genetic factors that influence
the geographical and racial disparities on the burden of ICAS, a better understanding of
such associations in the U.S population would strengthen of scientific evidence, and help
identify populations at risk that can potentially be targeted for medical and lifestyle
interventions. We assessed the hypotheses that high sensitivity C-reactive protein (hsCRP), a marker of inflammation is associated with asymptomatic ICAS in the U.S.
population.
2.3 Methods
Study Population
The ARIC study is a community-based, prospective cohort of 15,792 black and
white participants, aged 45 to 64 years recruited in 1987 to 1989 randomly selected from
7

4 communities (Forsyth County, NC; Jackson, MS; suburbs of Minneapolis, MN; and
Washington County, MD). First visit (baseline) took place from 1987 to 1989, with 4
subsequent visits: Visit 2 (1990–1992); Visit 3 (1993–1995); Visit 4 (1996–1998), and
Visit 5 (2011–2013). Among 10,036 participants who were still alive at the time of study,
6538 (65%) took part in Visit 5. High-resolution magnetic resonance angiography (MRA)
was offered to an age-stratified random sample of the participants from Visit 5 (n =
1,959). Of these 1,704 participants completed the study per study protocol with adequate
image quality. For our analysis, we excluded participants with missing information on hsCRP (n = 235). We also excluded those with history of stroke (n=11) and nonwhite or
nonblack participants (n=3), because of the small number. After excluding these, a total
of 1,455 participants met our inclusion criteria and their data were included in our
analysis.
Assessment and classification of Intracranial Atherosclerosis
A sub cohort of ARIC participants who attended visit 5, completed high
resolution MRA per study protocol. Details of MRA protocols, quality control, and
reliability have been reported elsewhere (28). Briefly, all scans were performed on high
resolution 3-Tesla Siemens MRI scanners. Images were analyzed by seven certified
readers who were blinded on the information on participant characteristics. Percent inter
and intra-reader agreement for ordinal intracranial stenosis were 94.4% and 93.8%,
respectively. Intracranial vascular territories were categorized as intracranial internal
carotid artery (cavernous and supraclinoid segments), middle cerebral artery (M1-M3
segments), anterior cerebral artery (A1-A3 segments), posterior cerebral artery (P1-P3
segments), basilar artery, and vertebral artery (V4 segment), for right and left hemisphere
8

respectively. For each of the above intracranial vascular territories, the degree of stenosis
was measured according to the criteria established in the Warfarin-Aspirin Symptomatic
Intracranial Disease trial (i.e. no detectable stenosis, less than 50%, 51% to 70%, 71% to
99%, and complete occlusion) (29). For the purpose of our analysis these categories were
consolidated into 3 groups: no stenosis, < 50% stenosis, > 50% stenosis/complete
occlusion.
Assessment and Classification of hs-CRP
For all study participants, who attended visit 2 and visit 4 blood sample was
drawn after an 8 hour fasting period. Plasma levels of hs-CRP were determined by an
immunoturbidimetric assay at visit 2 (Roche Diagnostics, Indianapolis, IN), and using a
nephelometric method (Siemens Healthcare Diagnostics, Deerfield, IL). According to the
guidelines from the American Heart Association, hs-CRP levels were categorized into
three groups: low (hs-CRP <1 mg/l), moderate (hs-CRP 1–3 mg/l) and elevated (hs-CRP
>3 mg/l) (30). To assess longitudinal changes in hs-CRP levels over a period of 6 years,
we used the categories proposed by Parrinello et al. (31) : sustained low/moderate (hsCRP <3 mg/L at both visits 2 and 4); decreased (≥3 mg/L at visit 2 and <3 mg/L at visit
4); increased (<3 mg/L at visit 2 and ≥3 mg/L at visit 4); and sustained elevated (≥3 mg/L
at both visits 2 and 4). Additionally, we also assessed mean of the hs-CRP across Visit 2
and 4, and categorized this into Tertiles.
Covariates of interest
Date of birth, gender, and race were reported by study participants at baseline.
Cardiovascular risk factors measured at visit 4 included alcohol use (current, past, or
never), smoking history (current, past, or never), prevalent hypertension, prevalent
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diabetes, prevalent cardiovascular disease (CVD), cholesterol-lowering medication use,
BMI categories (normal, overweight and obese). We defined hypertension as blood
pressure of 140/90 mm Hg or higher, or use of antihypertensive medications; diabetes as
fasting glucose level of ≥ 126 mg/dL or non-fasting glucose level ≥ 200 mg/dL, or use of
antidiabetic medications; and dyslipidemia as total cholesterol level ≥ 240 mg/dL, lowdensity lipoprotein cholesterol level ≥ 160 mg/dL, high-density lipoprotein cholesterol
level ≤ 40 mg/dL, or triglyceride level ≥ 200 mg/dL, or use of cholesterol-lowering
medications. Physical activity measures were assessed at visit 3 and these were used to
calculate leisure time physical activity levels (LTPA). We categorized LTPA into 3
groups: (1) no LTPA; (2) less than minimum goal (<450 metabolic equivalent (MET)
min/wk); (3) meeting or exceeding the minimum goal (greater than 450 MET min/wk).
Statistical analysis
We used SAS version 9.4 (SAS Institute Inc., Cary, NC) to conduct all statistical
analyses. We compared baseline characteristics between the CRP groups, using the chisquare test for categorical variables and variance (ANOVA) for continuous variables.
Multinomial logistic regression models were used to calculate odd ratios (ORs) of the
effects of variables on the relationship between hs-CRP levels and ICAS. The variables
adjusted for were age, gender, race, education level, leisure time physical activity,
prevalent hypertension, cholesterol-lowering medication, body mass index, prevalent
diabetes. All statistical analyses were two-tailed, and a P value of 0.05 was considered
statistically significant.
2.4 Results
ICAS was prevalent in 30% of study participants and 10% had ICAS ≥50% (data
not presented in the tables). The mean age of study cohort was 63 years at visit 4. Over a
10

6 years period (between visit 2 and 4), nearly 50% of the study population had sustained
low or moderate hs-CRP (<3 mg/L at both visits) and about 25% of participants had
sustained elevated hs-CRP (>3 mg/L at both visits) (Table 2.1). In comparison to those
with sustained low or moderate hs-CRP, participants with sustained elevated hs-CRP
were more likely to be female or black (38% vs. 22% and 76% vs. 48%, respectively)
(Table 2.1). Participants with sustained elevated hs-CRP were more likely to have
prevalent hypertension, diabetes, CVD and obesity, and were less likely to be physically
active (Table 2.1). Participants who had a decrease in hs-CRP (>3 to <3 mg/L) over this
period were more likely to be taking cholesterol-lowering medications at visit 4 (Table
2.1).
Participants with sustained elevated hs-CRP had increased odds for moderate and
severe ICAS compared to those with sustained low/moderate hs-CRP (adjusted OR 1.57
and 1.66, respectively; Table 2.2). Increased hs-CRP over the course of 6 years was
associated with increased odds for severe ICAS and moderate ICAS (adjusted OR 1.89
and 1.35), though the association for moderate ICAS was not statistically significant
(Table 2.2).
Table 2.3 presents this analysis stratified by gender. There were no gender
specific differences in odds for ICAS, except decreased in hs-CRP appeared to be
protective for moderate ICAS in female (OR 0.44 vs. 1.48, for male and female
respectively), though this was not statistically significant.
We performed a sensitivity analyses where we assessed the mean hs-CRP
between Visit 2 and 4 and assessed its association with ICAS at Visit 5. For this analyses
hs-CRP was categorized into Tertiles. Tertile 1 was categorized as mean hs-CRP level
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less than 1.35 mg/dl, Tertile 2 as mean hs-CRP between 1.36 mg/dl and 3.58 mg/dl, and
Tertile 3 as mean hs-CRP at or above 3.56 mg/dl. Results for the odd ratio for moderate
and severe ICAS across Tertiles of mean hs-CRP are presented in Table 2.4. Briefly,
participants in Tertile 2 and 3 had higher odds for moderate ICAS (aORs 1.52 [95 CI 1.07
– 2.16] and 1.53 [95 CI 1.06 – 2.21]) and those in Tertile 3 had higher odds for severe
ICAS (aOR 1.97 (95 CI 1.16 – 3.34)
Participants with elevated hs-CRP had greater odds for severe ICAS compared to
those with low hs-CRP (< 1 mg/l), though these estimates didn’t meet statistical
significance (adjusted OR 1.61 and 1.72, respectively) (Table 3). Elevated hs-CRP at
visit 4, both in moderate (1-3 mg/l) and high (>3 mg/l) categories, was associated with
increased odds for moderate ICAS (adjusted OR 1.45 and 1.99, respectively), however
this was not case for elevated hs-CRP at visit 2 (Table 2.5).
2.5 Discussion
In this US population-based community study, we report a significant and
independent associations between elevated hs-CRP and asymptomatic ICAS as assessed
by high resolution MR Angiography. Our results show that sustained elevated-CRP (≥3
mg/L threshold) over a period of six years is a strong predictor for ICAS. Single
measures of elevated hs-CRP at two different time points in the study were associated
with increased odds for ICAS as well, however the most proximally measured value of
hs-CRP with reference to ICAS ascertainment may be more important than past
measurements. These findings support prior evidence that chronically high levels of
inflammation play an active role in endothelial insult and in long-term development of
atherosclerosis.
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Prior studies have shown an association between hs-CRP and extracranial
atherosclerosis (carotid and coronary artery) (21-26)), but data on association between
inflammation and ICAS is limited, particularly in Western populations. In a Chinese
cohort, Wang et. al. (27) showed elevated hs-CRP is a risk factor for ICAS. To our
knowledge ours is the first study to find such an association in the US population. In
comparison to the study design of Wang et. al., our study has several unique strengths.
First, the use of high resolution MRA is a very sensitive and specific diagnostic method
to assess ICAS (32,33). In comparison, Wang et. al used transcranial doppler (TCD) to
measure the presence of ICAS. Although TCD is a convenient non-invasive screening
method, it is not as accurate as an angiogram for determining ICAS (20). Furthermore,
use of MRA not only improves the diagnostic accuracy, it also enabled us to measure the
severity of ICAS. Second, we used two measures of hs-CRP to assess for “inflammation”
among study participants over a period of time. In contrast, Wang et al. used a single
measure of hs-CRP for their analyses. A single hs-CRP reading cannot account for its for
its inherent short-term variability (35,36). Per American Heart Association
recommendations, to reduce within-person variability while using hs-CRP as a marker for
inflammation, at least two measurements should be used (37). Indeed, our analyses
confirms as compared to a single measure, elevated sustained increases in hs-CRP had a
more robust association with ICAS.
Despite being a large community-based cohort study with good sample size, our
study has a few limitations. Firstly, we did not have baseline information for our study
participants on the outcome of interest (ICAS), our results can only be interpreted as an
association not temporal risk. Another potential limitation of this study is that time of
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ICAS ascertainment and hs-CRP measurement were not concurrent, thus it is possible we
may not have identified participants with significant changes in hs-CRP level from the
time it was measured to when ICAS was ascertained. This limitation however was
partially overcome by assessing CRP trends. Also, individuals who died over the 6-year
period were not accounted for. As elevated CRP is associated with excess mortality and
ICAS, this may have underestimated the associations reported in this study. Additionally,
extracranial carotid stenosis was not assessed in this study, thus we cannot comment if
the relationship between intra vs. extra-cranial stenosis is different. Despite these
limitations, to our knowledge this is the first study to assess the relationship between
ICAS and inflammation in the US population.
In conclusion, we found elevated hs-CRP to be an important predictor of ICAS in
the US population. Our results suggest that chronically sustained high level of
inflammation, as assessed through repeated measurements of hs-CRP is a stronger
indicator of disease development. Therefore, among population at risk, such as those
suffering with ischemic stroke, it is important to screen for ICAS for those with elevated
hs-CRP levels. On the same note, while considering risk factor stratification for
secondary stroke prevention in populations with known ICAS, it is also important to
monitor hs-CRP levels, and pursue targeted treatments to address chronic inflammatory
states. Further studies are needed to understand the mechanisms of hs-CRP in
asymptomatic ICAS.
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Table 2.1 Selected characteristics of the study population by six years change in hs-CRP
measured at visit 2 (1990-92) or visit 4 (1996-98)

Mean (SD) or
%

Mean (SD) or
%

Mean (SD)
or %

Sustained
Elevated (>3
mg/L at both
visits)
(N=363,
25.1%)
Mean (SD) or
%

Age

62.6 (5.7)

63.6 (5.9)

62.6 (5.6)

62.7 (5.6)

Female (%)

48.5 %

51.9 %

70.7 %

76.3 %

Race – Black (%)

22.1 %

25 %

24.4 %

38 %

9.26 %

13.93 %

15.15 %

37.96 %

41.79 %

39.67 %

52.78 %

44.28 %

45.18 %

Sustained
Increased
Decreased (>3
Low/Moderate
(<3 to >3
to <3 mg/L)
(<3 mg/L at
mg/L)
(N=108,
both visits)
(N=201,
7.5%)
(N=773, 53.5%)
13.9%)

Education
<High School 11.64 %
High School or
41.04 %
College
>College 47.09 %
Body Mass Index†

25.7 (3.7)

27.5 (4.2)

26.2 (4.3)

29.5 (5.6)

Hypertension (%)
Diabetes (%)

25.5 %

34.3 %

24.8 %

46.4 %

3.8 %

6.2 %

2.8 %

7.7 %

Dyslipidemia

32 %

36.5 %

27.8 %

35.1 %

Prevalent CVD

6.2%

11.5%

7.1%

11.8%

Never 44.5 %

47.6 %

36.8 %

41.1 %

Former 46.7 %

42.9 %

49.8 %

48.7 %

Current 8.8 %

9.5 %

13.4 %

10.2

Never 52.1 %

51.9 %

54.1 %

36.2 %

Former 25.7 %

25.5 %

24.5 %

36 %

Current 22.1 %

22.6 %

21.4 %

27.8 %

13.7 %

21.3 %

8.0 %

9.1 %

Smoking (%)

Alcohol (%)

Cholesterol
Lowering
Medications
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Table 2.2 Association of six years change in hs-CRP measured at visit 2 (1990-92) or
visit 4 (1996-98) with prevalent ICAS measured at visit 5 (2011-2013)
Moderate ICAS
Cases/
Total N
(%)

Odds
Ratio
(Crude
Model*)

Severe ICAS

Odds
Ratio
(Adjusted
model**)

Cases /
Total N
(%)

Odds
Ratio
(Crude
Model*)

Odds
Ratio
(Adjusted
model**)
1.66
(1.03 –
2.84)

Sustained
Elevated (>3
mg/L at both
visits)
Increased (<3
to >3 mg/L)

89/363 1.72 (1.22
(24.5%)
- 2.41)

1.57 (1.10
- 2.27)

42/363
(11.6%)

2.14 (1.30
- 3.50)

44/201 1.37 (0.90
(21.9%)
- 2.08)

1.35 (0.89
- 2.08)

26/201
(12.9%)

1.76 (0.98
- 3.17)

Decreased (>3
to <3 mg/L)

22/108 0.91 (0.49
(20.4%)
- 1.54)

0.84 (0.47
- 1.50)

9/108
(8.3%)

Sustained
Low/Moderate
(<3 mg/L at
both visits)

146/773 Reference
(18.9%)

Reference

62/773
(8%)

Area under
curve

0.56

0.61

1.89
(1.07 3.24)
1.07 (0.51
1.03
- 2.52)
(0.48 2.45)
Reference Reference

0.66

0.69

*Crude logistic regression models adjusted for age and sex only.
** Logistic regression models were adjusted for the following covariates: age, gender,
race, education level, leisure time physical activity (LTPA), prevalent hypertension,
cholesterol-lowering medication, body mass index, prevalent diabetes.
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Table 2.3 Association of six years change in hs-CRP measured at visit 2 (1990-92) or
visit 4 (1996-98) with prevalent ICAS measured at visit 5 (2011-2013) by gender
Moderate ICAS

Sustained
Elevated (>3
mg/L at both
visits)

M

F
Increased (<3 M
to >3 mg/L)

F
Decreased
(>3 to <3
mg/L)

M

F
Sustained
Low/Modera
te (<3 mg/L
at both visits)

M

F

Severe ICAS

Cases/
Total N
(%)

Odds
Odds
Ratio
Ratio
(Crude (Adjusted
Model*) model**)

Cases /
Total N
(%)

Odds
Ratio
(Crude
Model*)

Odds
Ratio
(Adjusted
model**)

26/77
(33.8%
)
56/249
(22.5%
)
14/53
(26.4%
)
26/129
(20.2
%)
6/48
(12.5%
)
11/49
(22.5%
)
85/367
(8.2%)

2.01
(1.15 –
3.51)
1.68
(1.10 –
2.58)
1.30
(0.66 –
2.58)
1.48
(0.87 –
2.52)
0.47
(0.19 –
1.17)
1.56
(0.73 –
3.29)
Referen
ce

12/77
(15.6%)

2.99
(1.36 6.55)
1.62
(0.87 3.01)
1.73
(0.68 4.38)
1.70
(0.82 3.53)
1.01
(0.35 2.85)
1.15
(0.37 3.58)
Referen
ce

2.18 (0.93
-5.08)

1.91
(1.06 –
3.42)
1.48
(0.86 –
2.50)
1.24
(0.60 2.52)
1.26
(0.86 –
2.50)
0.44
(0.17 –
1.09)
1.48
(0.69 –
3.19)
Referenc
e

52/339
(6.8%)

23/249
(9.2%)
8/53
(15.1 %)
13/129
(10.1%)
5/48
(10.4%)
4/49
(8.2%)
30/367
(8.17%)

1.33 (0.65
- 2.71)
1.64 (0.61
-4.40)
1.73 (0.82
- 3.64)
0.86 (0.29
- 2.54)
1.07 (0.32
-3.51)
Reference

23/339
(6.8%)

M: Male; F: Female
*Crude logistic regression models adjusted for age and sex only.
** Logistic regression models were adjusted for the following covariates: age, gender,
race, education level, leisure time physical activity (LTPA), prevalent hypertension,
cholesterol-lowering medication, body mass index, prevalent diabetes.

Table 2.4 Association of Tertiles of mean hs-CRP measured at visit 2 (1990-92) or visit 4
(1996-98) with prevalent ICAS measured at visit 5 (2011-2013)
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Moderate ICAS

Severe ICAS

Cases/
Total N
(%)

Odds Ratio Odds Ratio
(Crude
(Adjusted
Model*)
model*)

Cases /
Total N
(%)

Tertile
1a

84/487
(17.3%)

Reference

Reference

37/487
(7.6%)

Tertile
2a

110/477
(23.1%)

1.50 (1.06
– 2.12)

1.52 (1.07
– 2.16)

Tertile
3a

107/481
(22.3%)

1.65 (1.15
– 2.36)

1.53 (1.06
– 2.21)

0.71

0.74

***AUC

Odds
Ratio
(Crude
Model*)
Reference

Odds Ratio
(Adjusted
model**)

41/477
(8.6%)

1.12 (0.66
– 1.90)

1.14 (0.66 –
1.95)

61/481
(12.7%)

2.28 (1.38
– 3.79)

1.97 (1.16 –
3.34)

0.61

0.64

Reference

a

Tertile 1 was categorized as mean hs-CRP level less than 1.35 mg/dl, Tertile 2 as mean
hs-CRP between 1.36 mg/dl and 3.58 mg/dl, and Tertile 3 as mean hs-CRP at or above
3.56 mg/dl.
*Crude logistic regression models adjusted for age and sex only.
** Logistic regression models were adjusted for the following covariates: age, gender,
race, education level, leisure time physical activity (LTPA), prevalent hypertension,
cholesterol-lowering medication, body mass index, prevalent diabetes.
***Area Under Curve

Table 2.5 Association of hs-CRP measured at visit 2 (1990-92) or visit 4 (1996-98) with
ICAS assessed at visit 5 (2011-2013)
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Moderate ICAS

Severe ICAS

Cases/
Total N
(%)

Odds Ratio
(Crude
Model*)

Odds Ratio
(Adjusted
model**)

Cases /
Total N
(%)

Odds Ratio
(Crude
Model*)

Odds
Ratio
(Adjusted
model**)

75/389
(19.3%)

Reference

Reference

28/389
(7.2%)

Reference

Reference

1-3
mg/l

115/587
(19.6%)

1.06 (0.75
- 1.49)

1.04 (0.73 1.48)

60/587
(10.2%)

1.47 (0.87
- 2.48)

1.44 (0.81
- 2.44)

> 3 mg/l

111/469
(23.7%)

1.43 (1.01
- 2.05)

1.29 (0.90 1.91)

51/469
(10.9%)

1.88 (1.09
- 3.25)

1.61 (0.89
- 2.92)

0.57

0.61

0.65

0.68

59/365
(16.1%)

Reference

Reference

31/365
(8.5%)

Reference

Reference

1-3
mg/l

109/516
(21.1%)

1.48 (1.01
- 2.22)

1.45 (0.99 2.15)

40/516
(7.8%)

0.94 (0.51
- 1.61)

0.98 (0.56
- 1.71)

> 3 mg/l

133/564
(23.6%)

2.06 (1.14
- 3.02)

1.99 (1.32 3.01)

68/564
(12.1%)

1.82 (1.09
- 3.06)

1.72 (0.99
- 3.05)

0.61

0.63

0.68

0.73

Hs-CRP
Visit 2
< 1 mg/l

***AUC
Hs-CRP
Visit 4
< 1 mg/l

***AUC

*Crude logistic regression models adjusted for age and sex only.
** Logistic regression models were adjusted for the following covariates: age, gender,
race, education level, leisure time physical activity (LTPA), prevalent hypertension,
cholesterol-lowering medication, body mass index, prevalent diabetes. All covariates
were visit 4 values, except for LTPA which was assessed at visit 3.
***Area under the curve
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CHAPTER 3
DEVELOPMENT OF AN ADAPTED MEDITERRANEAN DIET SCORE
AND ITS VALIDATION ON AN AMERICAN DIET
3.1 Introduction
Cardiovascular diseases are the leading cause of morbidity and mortality in the
United States and worldwide. The Mediterranean diet is one of the best studied diets
known for its cardiovascular health benefits and has remained a focus of research interest
worldwide. Prior studies have shown adherence to a Mediterranean dietary pattern
reduces risk of cardiovascular diseases, metabolic syndrome, type 2 diabetes, certain
cancers, cognitive impairment, and dementia (38-43).
The traditional Mediterranean diet is characterized by a high intake of fish, whole
grains, unsaturated fats, plant proteins, nuts, legumes, fruits and vegetables, moderate
intake of alcohol, and low consumption of red meat, refined grains, and sweets (44). The
Mediterranean-style dietary recommendations as reflected by the Mediterranean diet
pyramid, are based on the traditional dietary pattern from the Greek island of Crete
(44,45).
The Mediterranean diet has been found to be an alternative to a healthy dietary
pattern in the US population (46). Indexes developed by Trichopoulou et al (42) and
Panagiotakos et al. (47) to quantify adherence to Mediterranean diet are well known.
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These scales were developed and studied on the population residing in the
Mediterranearegion. In the non- Mediterranean populations, the food items consumed
may vary a lot from a traditional Mediterranean dietary pattern, making it a challenge to
accurately assess an individual’s diet using the same instruments. Thus a few modified
and improvised indexes have been proposed in nutritional epidemiologic studies to assess
adherence to Mediterranean diet based on the study population characteristics and dietary
habits (48-51).
In this study, we developed an adapted Mediterranean diet score (aMDS) to assess
Mediterranean diet adherence and its associations in among participants of the
Atherosclerosis Risk in Communities Cohort. The purpose of this research is to describe
the methodology in development of the aMDS and to examine the content validity of this
score for an American Diet among participants of the Atherosclerosis Risk in
Communities Cohort.
3.2 Methods
Study population
The ARIC study is a community-based prospective cohort of predominantly
biracial (black and white) participants aged 45 to 64 years recruited in 1987 to 1989
randomly selected from 4 communities (Forsyth County, NC; Jackson, MS; suburbs of
Minneapolis, MN; and Washington County, MD). Dietary intake was assessed by an
interviewer-administered 66-item semi-quantitative food frequency questionnaire at
baseline visit (1987–1989). Our analytical sample consisted of 12,404 persons from the
baseline visit who completed the food frequency questionnaire, after excluding those
(n=404) with the missing nutritional data.
21

aMDS Components
The aMDS was adapted from the Mediterranean diet scores proposed by
Trichopoulou et al (42) and Panagiotakos et al. (47). For the calculation of aMDS we
included the following 11 food components: non-refined cereals (whole grains), fruits,
vegetables (excluding potatoes), nuts, legumes, fish, monounsaturated-to-saturated fat
ratio (as an alternative for olive oil), red and processed meats, dairy products, poultry and
alcohol.
We assigned scores in the range from 0 to 5 for the weekly consumption of each
of these food components. Each component of the aMDS was calculated based on the
updated recommended intakes of food in the Mediterranean diet pyramid (52).
Items assumed to be contributing towards recommended Mediterranean dietary
pattern received an incremental score ranging from 0 to 5, whereas consumption of food
items against the Mediterranean dietary pattern received scores on the inverse ordinal
scale (Table 1). For example, scores assigned to vegetable consumption (times/week)
ranged from 0 to 5 for the following categories: never, 1 to 6 times, 7 to 12 times, 13 to
20 times, 21 to 32 times and ≥ 6 times. However in contrast to the indexes proposed by
Trichopoulou et al and Panagiotakos et al, we excluded potatoes from vegetables because
of differences in preparation methods in the United States and in Europe (53).
Nut consumption was not included by the scale proposed by Panagiotakos et al,
and nuts were included as a combined category with fruits in the scale proposed by
Trichopoulou et al. We included nuts as a separate group in our index, and scores in the
range from 0 to 5 were assigned for the recommended weekly intakes. For alcohol
consumption, gender specific cut-offs were applied: a score of 5 was assigned for
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consumption of less than 28 g and 14 g of alcohol per day, score 0 for no consumption or
for consumption of greater than 70 g and 28 g per day in men and women, respectively,
and the cutoffs for subcategories between 0 and 5 were reassigned with even intervals
(54).
Olive oil consumption, an important component of Mediterranean diet, was not
measured in the FFQ used in ARIC. In our score we used the ratio of MUFAs to SFAs as
a representation of the olive oil component. The ratio was then divided into 6 even
categories based on percentiles, and a score of 0 to 5 was assigned in an incremental
scale. The aMDS ranged from 0 to 55, with higher values indicating greater adherence to
the Mediterranean diet (Table 1).
Content Validity of thre aMDS
We assessed content validity of the aMDS, based on certain nutrients that have
been documented in literature to be different in Mediterranean diet than Western diet. For
instance, nutrients such as n-3 fatty acids (ω-3), unsaturated fats, dietary fibers, certain
vitamins are rich in Mediterranean diet. We hypothesized nutrient contents of a
traditional Mediterranean diet will correlated with aMDS. List of all variables that were
tested included total daily intake of energy, fiber, saturated fat, trans fat, monounsaturated
fat, oleic acid (18:1), polyunsaturated fat, n-6 fatty acids, n-3 fatty acids, ratio (n-6):(n-3)
fatty acids, linoleic acid (LA) (18:2), α-linolenic acid (ALA) (18:3), alcohol,
eicosapentaenoic acid (EPA) (20:5), docosahexaenoic acid (DHA) (22:6), ß- Carotene,
lycopene, folate, Vitamins B6, C, D, E, calcium, magnesium, potassium, and high
sensitivity C-reactive protein (hs-CRP). Higher quintiles of aMDS were inversely
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associated with saturated fat, trans fat, oleic acid, the ratio (n-6):(n-3) fatty acids, and hsCRP.
Statistical Methods
We compared baseline characteristics between the aMDS quintiles, using the chi square
test for categorical variables and variance (ANOVA) for continuous variables. To assess
p-value for trends for the nutrients across aMDS quintiles, a simple linear regression test
was used.
3.3 Results
General and clinical participant characteristics of ARIC population according to
quintiles of the aMDS are shown in Table 2.2. Higher quintiles of MDS were
characterized by larger proportions of individuals with high educational levels.
Individuals in the higher MDS quintiles were less likely to be active smokers, had a lower
mean BMI, and had lower prevalence of existing chronic conditions including
hypertension, diabetes mellitus and stroke (Table 2.2).
The mean aMDS score for the ARIC cohort at the baseline visit was 26.3 (SD ±
5.3), out of maximum possible score of 55. Among the 11 food groups considered in the
aMDS, median component scores were highest for poultry, dairy, fruits, and the ratio for
MUFAs to SFAs (Table 2.3). The proportion of population that attained the maximum
score of 5 for an individual food component, was highest for poultry (55%), followed by
dairy (25%), alcohol intake (24% and 18% for men and women, respectively), and the
ratio for MUFAs to SFAs (18%). The majority of ARIC population failed to meet the
recommended intake of a food group (Table 2.3).
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The associations between aMDS quintiles and selected nutrients previously
shown in literature to corelate to the Mediterranean diet are shown in Table 3. Higher
quintiles of aMDS were found to have a significant and positive association with dietary
fiber, polyunsaturated fat, n-3 fatty acids (linolenic acid (18:3), eicosapentaenoic acid
(20:5), and docosahexaenoic acid (22:6)), alcohol, beta carotene, lycopene, folate,
Vitamins B6, C, D, E, magnesium and potassium. Whereas, higher quintiles of aMDS
were inversely associated with saturated fat, trans fat, oleic acid, the ratio (n-6):(n-3) fatty
acids, hs-CRP. In contrast to these expected associations consistent with previous studies,
we observed an unexpected positive association between the aMDS and total energy
intakes and n-6 fatty acids, and an unexpected inverse association with monounsaturated
fat and calcium intake.
3.4 Discussion
The aMDS index based on frequently eaten food that was adapted for the ARIC
population reflected nutrients related to the Mediterranean diet. For example, individuals
in the higher quintiles of the aMDS index had higher mean intakes of nutrient that were
beneficial for health such as dietary fiber, polyunsaturated fat (relative), n-3 fatty acids,
beta carotene, lycopene, folate, Vitamins B6, C, D, E. Whereas, higher quintiles of aMDS
were inversely associated with saturated fat, trans fat, oleic acid, the ratio (n-6):(n-3) fatty
acids, hs-CRP.
Several indexes to assess Mediterranean diet adherence have been previously
reported. The Mediterranean diet scores developed by Trichopoulou et al. (42) and
Panagiotakos et al. (47), are widely known. These indexes included 9 and 10 food
components respectively, and were developed and validated based on the natives
Mediterranean population. Few adapted scores have been since proposed on non25

Mediterranean populations, such as e S-MDS (55), MedDQI (47), the alternate MD score
(50), and Japanese-adapted MD score (51). The components of these indexes and their
scoring systems differ across studies.
In this study we developed a simple Mediterranean diet score adapted to an
American diet in the Atherosclerosis Risk in Communities Cohort based on the inherent
characteristics of the Mediterranean diet. The score was developed based on the
recommended intake of food in the updated Mediterranean diet pyramid (52). We
excluded potatoes from vegetables because the way potatoes are prepared in U.S. is quite
different from Mediterranean countries (53). We did not incorporate olive oil in our
score, because the FFQ used in the ARIC study did not capture this item. In addition,
consumption of olive oil is low in the United States. As an alternate, we used the ratio of
monounsaturated fatty acids to saturated fatty acids as an indirect parameter, which has
been used in prior studies (42, 50, 56, 57).
To test of content validity, this score was compared against various nutrients and
markers previously shown to be closely related to the Mediterranean diet. All the selected
nutrients had the expected positive or inverse associations with our instrument, except for
the total energy intakes and n-6 fatty acids and monounsaturated fat. Monounsaturated
fat is present in meat and may reflect higher meat consumption in the American diet. The
polyunsaturated fat in the American diet, e.g. use of canola oil that is preferred over olive
oil, may have higher n-6 content.
Some limitations of our data and perhaps also our instrument are as follows. For
most of the food components considered in our score, we did not account for
overconsumption. This may have resulted in confounding by energy intake, as by
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consuming higher amounts of foods, it may be easier to achieve recommended intakes,
however also consequently more energy intake. One way to compensate for this
limitation may be to adjust for total energy intake when analyzing these data in relation to
disease outcomes. The inverse association observed with monounsaturated fats could be
because in the traditional Mediterranean pyramid, olive oil is one of the important
sources for monounsaturated fats. On the contrary in the US population where olive oil
consumption is relatively low, much of the monounsaturated fats come from consumption
of beef (58), which may reflect the inverse association seen with our instrument as higher
quantity of red meat consumption received scores on the inverse ordinal scale. Finally the
positive association seen with ω-6 fatty acids may be multifactorial, and could be a
combination of not accounting for overconsumption of the food items, and may also
reflect the inability of the semiquantitative FFQ to quantify nutrients accurately and could
have affected the observed score-nutrient associations. Though importantly, both ω-6 and
ω-3 fatty acids are essential for health and must be obtained from the diet, and our
observed inverse association of (n-6):(n-3) fatty acid ratio is in the direction we would
expect with adherence of Mediterranean dietary pattern.
In conclusion, in this study we developed a simple literature based Mediterranean
diet score adapted to American diet, that shows reasonable associations with nutrient
intakes. In addition, aMDS adherence was associated with a lower prevalence of chronic
conditions including hypertension, diabetes mellitus and stroke. The Mediterranean diet
has been globally recognized as a healthy diet. It makes sense to encourage US
population to adapt the Mediterranean dietary patterns to prevent chronic diseases. This
aMDS index could be used to assess adherence to Mediterranean diet in future studies.
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Table 3.1 Components of the aMDS1
Components of the
adapted2
Mediterranean diet
score
Nuts
Fruits
Vegetables
Fish
Ratio of MUFAs to
SFAs
Non refined cereals
Legumes
Red meat and
products
Poultry
Dairy products
Alcoholic
beverages (g/day)
Men
Women

Scores3
2

0

1

Never
Never
Never
Never
1st sextile

<1
1-4
1-6
<1

Never
Never
≥ 11

1-6
<1
8-10

7-12
1-2
6-7

≥ 11
≥ 31

9-10
29-30

7-8
21-28

0 or > 70 gm
gm
0 or > 28 gm
gm

3

4

5

3-4
16-21
21-32
5-6

≥5
≥ 22
≥ 33
≥7
th
6 Sextile

13-18
3-4
4-5

19-31
5-6
2-3

≥31
≥7
≤1

5-6
16-20

4-5
11-15

≤3
≤ 10

1
2
5-8
9-15
7-12
13-20
1-2
3-4
Even percentile cut offs

Even interval cut offs

> 0 and < 28
> 0 and < 14

1 Values are frequencies in times/week for food components unless otherwise stated
2 Food items included apple, pears, orange, grape fruit, peaches, apricots, plums, banana,
other fruits for fruits; cooked cereals such oatmeal grits and cream of wheat, other
cereals, dark or whole grain breads, and corn bread for grains; beans, lentils, peanuts for
legumes; carrots, broccoli, brussels sprouts, cauliflower, tomatoes, spinach, collard or
other greens, green or lima beans, cabbage, cauliflower, squash, and any other vegetables
for vegetables; clams, shrimp and any variety of fish for fish; milk (whole or regular and
or low-fat milk), yogurt, ice cream, cheese, cheese dishes, and butter for dairy products;
bacon, hamburgers, hotdogs and other processed meats such as sausage, salami, bologna
etc., beef, pork, and ham for red meat and products; and chicken and turkey for poultry.
3 The top score contributes toward and the bottom score contributes against the
Mediterranean diet. The total dietary score for an individual is the sum of individual
scores for each of the 11 dietary components making up the aMDS. The possible overall
aMDS ranged from 0 to 55, with higher values indicating greater adherence to the
Mediterranean diet.
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Table 3.2 Intake and score distributions of aMDS food components in the ARIC cohort
Components of the adapted
Mediterranean diet score

Intake
Distribution*
Median (5th ,
95th percentile)

Participants
meeting
recommended
intake

0.5 (0, 3)

Score
Distribution
Median (5th ,
95th
percentile)
1 (0, 4)

Nuts
Fruits
Vegetables
Fish
Ratio of MUFAs to SFAs**
Non refined cereals (wholegrain)
Legumes

10 (2.5, 23)
11 (4, 22.5)
1.5 (0, 4)
1.1 (0.9, 1.3)
8 (1.5, 21)

3 (1, 5)
2 (1, 4)
2 (0, 3)
3 (0, 5)
2 (1, 4)

12.5 %
2.8 %
4.3 %
17.8 %
1.0 %

1.5 (0, 6)

2 (0, 4)

8.3 %

Red meat and products
Poultry
Dairy products
Alcohol intake (g/day)
Male
Female

6 (1.5, 13)
3 (0.5, 6)
17 (6.5, 34)

2 (0, 5)
4 (3-5)
3 (0 -5)

12.2 %
55%
25.3 %

0 (0, 40)
0 (0, 15)

0 (0, 5)
0 (0, 5)

24 %
18.3 %

4.0 %

*Servings per week, unless otherwise specified; ** Ratio derived from the daily intake of
MUFAs and SFAs
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Table 3.3 Distribution of general and clinical characteristics of ARIC population
according to quintiles of the adapted Mediterranean diet score
Adapted Mediterranean diet score quintiles (range)
Characteristics Q1 (3-22)
n=2,583

Female %
Black Race (%)
College
Educated (%)
Current
Smokers (%)
BMI

56.3
19.7
42.1

58.8
22.4
451

Q3
(25.1-28)
n=2,471
59.8
(0.7)
57.0
22.1
45.9

15

14

11

25.4 (1.8)

HTN
LDL (mean,
SE)
Prevalent CAD
Prevalent DM
Prevalent
Stroke

39.7
126.6
(34.4)
6.0
10.7
8.2

26.1 (1.5) 25.6
(1.4)
40.0
40.1
126.8
128.03
(34.7)
(34.7)
5.2
5.1
10.1
9.3
7.2
7.3

Age (mean, SE) 59.9 (0.8)

Q2 (22.125)
n= 2,487
59.8 (0.9)

Q4 (28.131)
n=2,477
60.1 (0.9)

Q5 (31.149)
n=2,377
60.2 (0.8)

Pvalue

54.3
22.7
49.4

49.7
23.8
53.1

0.10
0.05

9

7

< 0.01

25.1 (1.9)

24.2 (1.6)

0.01

38.8
127.2
(34.6)
5.1
9.2
7.9

37.6
126.7
(34.6)
6.1
7.9
5.9

0.03
0.56

0.72

0.45
0.03
0.02

Table 3.4. Selected daily intakes of nutrients associated with the aMDS quintiles in the
ARIC Cohort
Nutrients

Adapted Mediterranean diet score quantiles (range)
Q1 (3 –
22)

Q2 (22.1
– 25)

Q3 (25.1
– 28)

Q4 (28.1
– 31)

Q5 (31.1
– 49)

n

2,583

2,487

2,471

2,477

2,377

Energy intake,
kJ

1,596

1,530

1,589

1,615

1,720

<
0.001

Fiber, g

13.5

15.8

17.8

19.3

23.4

<
0.001

Saturated fat, g

23.9

20.1

19.6

18.5

17.6

<
0.001

Trans fat, g

2.2

2.1

2.1

2.0

2.0

0.04

22.0

22.2

21.9

21.8

<

Monounsaturate 24.2
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P-trend

d fat, g

0.001

Oleic acid
(18:1), g

22.1

20.0

20.3

20.0

19.9

<
0.001

Polyunsaturated
fat, g

8.2

8.1

8.5

8.8

9.7

<
0.001

n-6 Fatty acids1, 7.1
g

7.0

7.3

7.5

8.2

<
0.001

n-3 Fatty acids2, 0.96
g

0.95

1.01

1.05

1.20

<
0.001

Ratio (n-6):(n3) fatty acids

7.4

7.4

7.2

7.1

6.8

0.01

LA (18:2), g

7.0

6.8

7.2

7.4

8.1

<
0.001

ALA (18:3), g

0.8

0.7

0.7

0.7

0.6

0.01

Alcohol, g

4.2

4.1

4.7

5.7

6.6

<
0.001

EPA (20:5) +
DHA (22:6), g

0.16

0.19

0.27

0.36

0.42

<
0.001

ß- Carotene, µg

2119.3

2781.3

3252.1

3611.4

4653.3

<
0.001

Lycopene, µg

846.3

946.3

1074.2

1202.9

1435.6

<
0.001

Folate, µg

216.1

238.8

257.7

274.1

322.7

<
0.001

Vitamin B6

1.7

1.8

1.9

2.0

2.2

<
0.001

Vitamin C, mg

109.5

123.8

130.7

139.5

163.7

<
0.001

Vitamin E, mg

4.1

4.6

5.1

5.6

6.8

<
0.001

Vitamin D, mg

250.9

240.2

254.3

260.1

302.1

0.01

Calcium, mg

738.6

654.9

644.8

655.6

643.6

0.01

Magnesium, mg 229.1

236.2

253.5

265.6

302.5

<
0.001

Potassium, mg

2479

2540

2685

2759

3094

<
0.001

hS-CRP (Mean,

3.0 (0.2)

2.8 (0.2)

2.7 (0.3)

2.5 (0.2)

2.2 (0.3)

<

31

SD)

0.001

LA: Linoleic acid; ALA: α-linolenic acid; EPA: Eicosapentaenoic acid; DHA:
Docosahexaenoic acid
1
(n-6) Fatty acids included 18:2(n-6) (LA) and 20:4(n-6).
2
(n-3) Fatty acids included 18:3(n-3) (LNA), 20:5(n-3) (EPA), and 22:6(n-3) (DHA).
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CHAPTER 4
ASSOCIATION OF MEDITERRANEAN DIET ADHERENCE WITH
INTRACRANIAL ATHEROSCLEROSIS, AND ITS ASSESSMENT OF
EFFECT MODIFICATION BY INFLAMMATION
4.1 Introduction
Stroke is the third leading cause of death in the United States. Despite recent
advances in acute stroke treatment, effective primary stroke prevention, by means of
improved control of vascular risk factors, has the greatest potential to reduce its burden
(59). Intracranial atherosclerotic disease (ICAD) of major cerebral vessels is a wellestablished vascular risk factors for ischemic stroke (60,61). The American Heart
Association (AHA) has emphasized on the importance of a healthy diet for the primary
and secondary prevention of cardiovascular diseases including stroke (62).
The western diet, rich in red meat, processed and artificially sweetened food
products, refined grains, high fat-dairy products, and sugar-sweetened beverages, has
been linked with increased levels of inflammatory biomarkers and increased risk for
atherosclerotic disease (63). On the contrary, a Mediterranean dietary pattern, rich in
nuts, olive oil, legumes and fish, fruits and vegetables, moderate intake of wine, has been
Current AHA guidelines specifically recommend Mediterranean-style diet as a
lifestyle measure to reduce risk for clinical vascular events including stroke (62). Prior
observational studies have shown inverse association between certain healthy eating
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patterns and risk factors for atherosclerosis, including inflammatory biomarkers and
endothelial function (67-70). Given the anti-inflammatory properties of Mediterranean
diet (Med-Diet), at least in part the association between a Mediterranean diet and risk of
stroke may be mediated by intracranial atherosclerotic disease (ICAD). However, to our
knowledge the direct relationship between Med-Diet and ICAD has not been studied
before.
The objective of our study was to examine the relationship between
Mediterranean dietary pattern and ICAD in the Atherosclerotic Risk in Communities
Study (ARIC). We hypothesized those who adherence to Mediterranean dietary pattern
would be associated with lower burden of ICAD. We further assessed whether the
association between Med-diet adherence and intracranial atherosclerotic disease is
modified by inflammation. The examination of a Med-Diet in relation to both ICAD and
inflammation, in a population-based US cohort makes the current study an important
contribution to the literature on the potential benefits of a Med-Diet.
4.2 Methods
Study Population
The ARIC study is a community-based, prospective cohort total of 15,792 black
and white participants, aged 45 to 64 years recruited in 1987 to 1989 randomly selected
from 4 communities (Forsyth County, NC; Jackson, MS; suburbs of Minneapolis, MN;
and Washington County, MD). Dietary intake was assessed by an intervieweradministered 66-item semi-quantitative food frequency questionnaire at baseline visit
(1987–1989). Among 10,036 participants who were still alive at the time of study, 6538
(65%) took part in Visit 5. High-resolution magnetic resonance angiography (MRA) was
offered to an age-stratified random sample of the participants from Visit 5 (n = 1,959), of
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these 1,704 participants completed the study per study protocol with adequate image
quality. From this sample, we excluded those who did not complete the baseline
quantitative food frequency questionnaire (n = 259). We further excluded participants
with missing information on Mediterranean dietary components (n=64) and nonwhite or
black participants (n=3). After excluding these, a total of 1,378 participants met our
inclusion criteria and their data were included in our analysis.
Assessment and classification of Intracranial Atherosclerosis
A sub cohort of ARIC participants who attended visit 5, completed high
resolution MRA per study protocol. Details of MRA protocols, quality control, and
reliability have been reported elsewhere (71). Briefly, all scans were performed on high
resolution 3-Tesla Siemens MRI scanners. Images were analyzed by seven certified
readers who were blinded on the information on participant characteristics. Percent inter
and intra-reader agreement for ordinal intracranial stenosis were 94.4% and 93.8%,
respectively. Intracranial vascular territories were categorized as intracranial internal
carotid artery (cavernous and supraclinoid segments), middle cerebral artery (M1-M3
segments), anterior cerebral artery (A1-A3 segments), posterior cerebral artery (P1-P3
segments), basilar artery, and vertebral artery (V4 segment), for right and left hemisphere
respectively. For each of the above intracranial vascular territory, the degree of stenosis
was measured according to the criteria established in the Warfarin-Aspirin Symptomatic
Intracranial Disease trial (i.e. no detectable stenosis, less than 50%, 51% to 70%, 71% to
99%, and complete occlusion) (72). For our primary analysis these categories were
consolidated into 3 groups: no stenosis, < 50% stenosis, ≥ 50% stenosis/complete
occlusion.
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Assessment of Mediterranean dietary adherence
At baseline, ARIC participants completed a comprehensive intervieweradministered 66-item semi-quantitative food frequency questionnaire at baseline visit
(1987–1989). This questionnaire was intended to represent typical food consumption
over the previous year. Participants were asked to record how often each food was eaten.
We constructed an adapted Med-Diet score (aMDS) that has been adapted from
proposed Med-Diet adherence scores as proposed by Trichopoulou et al (73) and
Panagiotakos et al. (74). This score has been previously validated on ARIC cohort
(Trivedi et al.). For the calculation of aMDS we included the following 11 food
components: non-refined cereals (whole grains), fruits, vegetables (excluding potatoes),
nuts, legumes, fish, monounsaturated-to-saturated fat ratio (as an alternative for olive oil),
red and processed meats, dairy products, poultry and alcohol. We assigned scores in the
range from 0 to 5 for the weekly consumption of each of these food components. Each
component of the aMDS was calculated based on the updated recommended intakes of
food in the Med-Diet pyramid (75). Items assumed to be contributing towards
recommended Mediterranean dietary pattern received an incremental score ranging from
0 to 5, whereas consumption of food items against the Mediterranean dietary pattern
received scores on the inverse ordinal scale.
The aMDS ranged from 0 to 55, with higher values indicating greater adherence
to the Mediterranean diet. The aMDS, the primary exposure of interest, was analyzed by
dividing the distribution score into Tertiles.
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Covariates of interest
Age, gender, and race were reported by study participants at baseline.
Cardiovascular risk factors included alcohol use (current, past, or never), smoking history
(current, past, or never), prevalent hypertension, prevalent diabetes, cholesterol-lowering
medication use, BMI categories (normal, overweight and obese). We defined
hypertension as blood pressure of 140/90 mm Hg or higher, or use of antihypertensive
medications; diabetes as fasting glucose level of ≥ 126 mg/dL or non-fasting glucose
level ≥ 200 mg/dL, or use of antidiabetic medications; and dyslipidemia as total
cholesterol level ≥ 240 mg/dL, low-density lipoprotein cholesterol level ≥ 160 mg/dL,
high-density lipoprotein cholesterol level ≤ 40 mg/dL, or triglyceride level ≥ 200 mg/dL,
or use of cholesterol-lowering medications. We categorized hs-CRP levels into two
groups: low to moderate (hs-CRP ≤ 3 mg/l) and elevated (hs-CRP >3 mg/l).
Statistical analysis
The distribution of covariates of interest across aMDS Tertiles was examined
using chi-square tests for categorical variables and analysis of variance for continuous
variables. For the analyses aimed to assess the association between aMDS and ICAD,
logistic regression models were constructed with ICAD as the dependent variable. We
used a sequence of two models to assess the association between aMDS and levels of
ICAD: 1) adjusted for age and sex; 2) adjusted for age, sex, race, education, prevalent
diabetes, hypertension, hyperlipidemia and body mass index.
Lastly, we examined the effect for aMDS on ICAD is modified by inflammation
(as measured by level of hs-CRP, as a dichotomous variable). For this analysis we
categorized both aMDS and ICAD as a dichotomous variable: aMDS was categorized as
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Adherent (above median score) vs. Non-adherent (below median score); ICAD as < 50%
Stenosis vs ≥ 50% Stenosis.
For this, we calculated ORs for ICAD in each stratum of aMDS and hs-CRP, with
the stratum with 3rd tertile of aMDS and hs-CRP < 3 mg/dl as the reference category. We
calculated ORs for ICAD by Med-Diet adherence within strata of hs-CRP.
Finally, we presented measures of effect modification on both additive (relative
excess risk due to interaction “RERI” [76,77]) and multiplicative scales with CIs and Pvalues.
We used SAS version 9.4 (SAS Institute Inc., Cary, NC) to conduct all statistical
analyses. All statistical analyses were two-tailed, and a P value of 0.05 was considered
statistically significant.
4.3 Results
Our analytic sample included 1,378 participants, who underwent MR
Angiography and had diet data available to calculate Mediterranean diet score. The mean
age of the participants was 59 ± 5 years, 60% were women, 75% were white, 47%
attained higher than college education. For our study participants, aMDS ranged between
3 to 49. We categorized aMDS into Tertiles: Tertile 1 ranged from aMDS 3-23; Tertile 2
from aMDS 24-28; Tertile 3 from aMDS 29-49.
Characteristics of the study population stratified by aMDS tertiles are shown
in Table 1. In the univariate analyses, male sex, those with higher than collage education
were associated with greater adherence to Med-Diet pattern, while elevated BMI,
hypertension, diabetes, dyslipidemia and diabetes were associated with lower
consumption of a Mediterranean diet.
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Table 2 shows the association between the aMDS Tertiles, and severe ICAS (≥
50% stenosis). The prevalence of severe ICAS was higher in those with the lowest Tertile
of aMDS (10.1 % for Tertile 1 vs. 9.7% for Tertile 2 vs. 9.4% for Tertile 3). In the
adjusted logistic regression models, nonadherence to Med-Diet was associated with
increased odds for severe ICAS (OR 1.27 and 1.19, for Tertile 1 and 2, respectively),
however these results were not statistically significant.
We investigated whether the association of adherence to Mediterranean diet on
ICAD was modified by the hs-CRP level. Hs-CRP was dichotomized as ≤ 3 mg/dl (low)
or > 3 mg/dl (high). Odds ratios representing single and joint effects for Mediterranean
diet (highest and lowest Tertile) and hs-CRP categories are presented in Table 4.3.
Among individuals with high hs-CRP, non-adherence to Mediterranean diet was
associated with higher odds for severe ICAS (aOR 1.45 [CI 0.876 – 2.3]), where aMDS
adherence and low hs-CRP was the reference group. The RERI was calculated as 0.6 with
a 95% CI obtained by the delta method (20) of (CI -0.12 - 0.94). The measure of
interaction on a multiplicative scale, the ratio of ORs in strata of the hs-CRP, was 1.74
(0.68 – 3.20). Though not statistically significant, our findings were suggestive of
positive effect modification on an additive and multiplicative scale. The relation between
Med-Diet adherence and ICAD was adjusted for age, sex and race.
4.4 Discussion
The relation between Med-Diet and ICAD was not statistically significant in
these analyses. However, our findings showed some suggestion that greater adherence to
a Med-Diet may be associated with a decreased burden of severe ICAD. Possible
explanations for not seeing a significant association could have been multifactorial. First,
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between capturing diet and assessing ICAD there was a time difference of two decades,
and individual’s dietary habits could have been changed over this period for different
reason. There have been many secular changes in American diet over this period. Factors
like changes in national food supply, policy environment, scientific evidence and dietary
recommendations may play a role (78). It is possible that with advancing age many
participants may have changed their dietary pattern either owing to preference or because
of competing risk factors (e.g. development of other chronic conditions), which could
have led to misclassification of an individual’s diet. Second, the dietary pattern of our
cohort may not accurately reflect a truly Mediterranean diet. In reference to the
recommended intake of individual components of Mediterranean diet, the consumption of
vegetables, fruit, fish, and cereals was less in our cohort. Also this was less in reference
to some other American cohorts which have assessed Mediterranean diet (79, 80, 81). In
comparison to traditional Mediterranean diet, we also observed variations in some
derived nutrients. For instance, we saw an inverse association for MUFAs, which are
mostly derived from olive oil, then expected in Mediterranean diet. Overall, the dietary
habits of our cohort at baseline were less consistent with a Mediterranean-style pattern.
Multiple risk factors for ICAD, including smoking, hypertension, diabetes
have been previously reported. Med-Diet have been linked with extracranial
atherosclerosis including coronary artery disease (84,85) and cervical carotid stenosis
(86,87), however no prior study to our knowledge has specifically studied diet as a risk
factor for intracranial atherosclerosis. Although extracranial atherosclerosis and
intracranial atherosclerosis share multiple common risk factors, differences still exist
between them (88,89). For example male sex and hyperlipidemia have been shown to
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tend to be more important in extracranial atherosclerosis than ICAD, while metabolic
syndrome favors posterior circulation of the intracranial vessels (88). Different vessel
wall structure and hemodynamics of intracranial vs. extracranial arteries may partly
explain some of the observed differences, as this may vary the response to various
pathophysiological processes [88,90]. Thus, it is important to identify modifiable risk
factors specific for intracranial atherosclerosis, like diet, that can be used as a
management strategy to address ICAD among high risk populations.
The cardiovascular protective effects of Med-Diet are multifactorial. Some of
the well-studied mechanisms include reduced inflammation, decreased platelet
aggregation, reduced oxidative stress, improved lipid profile, improved blood pressure,
and weight reduction. Clearly no mechanism can independently account for observed
cardiovascular benefits by itself, and there is often a complex interplay between these
mediators.
Our findings suggest, inflammation modifies the observed association
between Med-Diet and ICAD. Nonadherence to Med-Diet was associated with an
increased burden of ICAD, however this association was only significant in those with
high hs-CRP levels. The combined effect of Med-Diet and hs-CRP was a little larger than
sum of their individual effects suggesting a possible synergistic interaction. This could
imply that certain at-risk population with a high hs-CRP level, adherence to a
Mediterranean pattern diet can reduce risk for intracranial atherosclerotic disease, and
thus eventually ischemic strokes.
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The strengths of our study include (1) it is large population-based cohort,
with high rate of patient follow up within the ARIC cohort; (2) dietary data and vascular
risk factors were rigorously measured as a part of the ARIC cohort, (3) the availability of
high resolution MR Angiography data to assess the degree of ICAD, (4) MR
Angiography protocols and interpretation was standardized across centers.
However, our study also had some limitations. First, since we did not have
serial ICAD measurements, our analysis is partially cross-sectional, and any assumption
on causality of the observed association would be subject to bias. Second, since we only
have baseline data on diet, it may not reflect lifelong dietary habits of participants. Third,
it is possible that some participants change their dietary habits and switch towards an
unhealthy dietary pattern as they age, resulting in misclassification and underestimation
of the effect size. Reverse causation is also possible, as those with underlying risk factors
may modify their diet to a healthier pattern.
In conclusion, our study is the first large observational population-based
study to examine the relationship between Med-Diet and ICAD. Our findings suggest that
dietary pattern consistent with a Med-Diet may have some benefits to reduce burden of
ICAD, an important risk factor for stroke. The benefits of Med-Diet may even be higher
in those with underlying increased inflammatory states. Investigations using prospective
study designs are needed to assess how adherence to a Med-Diet may impact the
trajectories of markers of inflammation, which modify the risk of intracranial
atherosclerosis and vascular outcomes, over time. Further research on the role of diet on
ICAD should be a public health priority because it is a modifiable behavioral risk factor.
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Table 4.1 Selected characteristics of the study population by Tertiles of Mediterranean
diet score (n=1,378)
Cohort
(n=1,378)

First Tertile
(n=454)

Second Tertile
(n=476)

Third Tertile
(n= 446)

Mean (SD) or
%
58.6 (5.1)

MD Score 3 24
58.4 (5.1)

MD Score 25
- 28
58.5 (5.6)

MD Score 29 49
59.1 (5.3)

Female (%)

59.5 %

62.9 %

60.4 %

53.9 %

Race – Black (%)

25.1 %

22.9 %

23.5 %

22.2 %

<High School

12.3 %

18.5 %

11.4 %

8.9 %

High School or
College
>College

40.6 %

43.4 %

41.3 %

37.8 %

47.1 %

38.2 %

47.3 %

53.3 %

Body Mass Index†

26.8 (4.1)

27.2 (4.7)

26.8 (4.5)

26.32(4.1)

Hypertension (%)

31.4 %

37.5 %

29.4 %

27.1 %

Diabetes (%)

7.5 %

8.2 %

7.4 %

7.2 %

Dyslipidemia

17.3 %

20.0 %

17.2 %

15.0 %

Current Smoker
(%)

9.5 %

11.39%

11.9 %

6.0%

Age

Education

Table 4.2 Logistic regression models with Odds Ratios for ICAS categories by aMDS
Tertiles
Severe ICAS (≥ 50%)
Cases / Total N (%)

Odds Ratio
(Crude Model*)

Odds Ratio
(Adjusted model**)

aMDS Tertile 1

46/454 (10.1%)

1.33 (0.80 - 2.22)

1.27 (0.78 - 2.09)

aMDS Tertile 2

46/476 (9.7%)

1.28 (0.81 - 2.20)

1.19 (0.75- 2.07)

aMDS Tertile 3

42/446 (9.4%)

Reference

Reference

0.68

0.71

***AUC
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*Crude logistic regression models adjusted for age and sex only.
** Logistic regression models were adjusted for the following covariates: age, sex, race,
education, prevalent diabetes, hypertension, hyperlipidemia, and body mass index.
***Area Under Curve

Table 4. 3 Odds ratios representing single and joint effects for Mediterranean diet
(highest and lowest Tertile) and hs-CRP categories.
Med-Diet Adherence*
N
OR (95%
with/without
CI)
ICAS

Med-Diet Nonadherence*
N
OR (95%
with/without
CI)
ICAS

OR (95%
CI) for
ICAD by
Med-Diet
nonadherence
within
strata of hsCRP
Hs-CRP ≤ 26/258
1
18/241
0.78 (0.42 – 0.78 (0.42
3
1.28);
– 1.28);
P=0.10
P=0.10
Hs-CRP
16/146
1.07 (0.59 – 26/169
1.45 (0.87- 1.35 (0.75
>3
1.95)
2.36);
– 2.42);
P=0.09
P=0.47
Measure of effect modification on additive scale: RERI (90% CI) 0.6 (-0.12 - 0.94);
P=0.22;
Measure of effect modification on multiplicative scale: ratio of 1.74 (0.68 – 3.20);
P=0.43;
ORs are adjusted for age and sex, race
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CHAPTER 5
SUMMARY
Does inflammation play a role in ICAS? Is it an important driving force in ICAS
or just an epiphenomenon? Besides optimal medical management is there a space for
targeted lifestyle interventions such as diet in the management of ICAS? These were few
of the questions we sought to understand in this research.
Atherosclerotic stenosis of intracranial vessels as a disease has a complex genesis.
Based on the current understanding of the risk factors for ICAS, targeting blood pressure,
cholesterol and cigarette smoking has remained the corner stone for the medical
management of ICAS and secondary stroke prevention. Although clinical and
observational studies have provided evidence for role of inflammation, at least in the
extracranial atherosclerotic disease and cardiovascular prevention, many clinicians do not
see any reason to consider screening and managing inflammation as part of the
preventive strategy, nor does this reflect in current guidelines for stroke prevention. The
results from our study demand a reassessment of the situation.
Our findings show inflammation plays a key role in stenosis of major intracranial
vessels. More specifically, chronically high level of inflammation, as assessed through
repeated measurements of hs-CRP was found to be associated with ICAS. These findings
support prior evidence that chronically high inflammation play an active role in
inflammation has been linked with cardiovascular diseases including ischemic stroke, it is
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likely ICAS may be playing a part on a causal pathway, as an intermediate risk factor
linking inflammation and ischemic stroke. Our findings suggest that greater adherence to
a Mediterranean dietary pattern may have some benefits in prevention of ICAS. The
cardiovascular protective effects of Mediterranean diet could be multifactorial. Some of
the well-studied mechanisms include reduced inflammation, reduced oxidative stress,
improved lipid profile, improved blood pressure, and weight reduction. Furthermore, our
analyses indicates inflammation modifies the observed association between
Mediterranean diet and ICAS, whereas nonadherence to Mediterranean appears to be
associated with an increased burden of ICAD, however this association was only
meaningful in those with high hs-CRP level. It implies that in those with chronic
inflammation, adherence to a Mediterranean pattern diet can reduce risk for intracranial
atherosclerotic disease, and thus eventually ischemic strokes.
It is important to improve our understanding on the role of inflammation as a risk
for atherosclerotic disease. Among population at risk, such as those suffering with
ischemic stroke, it is important to screen for elevated hs-CRP levels for those with ICAS,
and vice-versa. Current clinical practice guidelines do not recommend screening for
inflammation for those with symptomatic or asymptomatic ICAS, however this should be
a consideration.
While considering risk factor stratification for secondary stroke prevention in
population with known ICAS, it is also important to monitor hs-CRP levels, and pursue
targeted treatments to address chronic inflammatory states. We have limited evidence on
the benefits of managing inflammation with pharmacological agents for primary and
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secondary cardiovascular prevention. Investigations using prospective study designs are
needed to assess how healthy lifestyle changes such as adherence to a Mediterranean
Dietary pattern may impact the trajectories of markers of inflammation, which can
modify the risk of intracranial atherosclerosis and vascular outcomes, over time. Further
research on the role of inflammation on vascular intermediate risk factors such as ICAD,
and understanding its modifiable behavioral risk factors such as diet should be a public
health priority.
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